Frontlight ResearchEarly access
Metastatic breast cancer trials in Bulgaria
1 of 7 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer
- Where
- Burgas, Panagyurishte, Plovdiv, Sofia, Stara Zagora, Varna
- Age
- 18 years and over
- People
- 138 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06727227